RAD

Face-Off on Stocks: Walgreen, CVS, Rite Aid

Not everyone is happy about the mild start to the cold-and-flu season. The nation's drugstore chains, already under pricing pressure from Walmart and each other, would be happier if the rest of us had coughs and sniffles. Here are bull and bear cases for the three big chains.

Rite Aid Reports Narrower Loss and Lower Revenue

Rite Aid posted Wednesday morning a narrower loss of $73.7 million, or 9 cents per in its fiscal first quarter, compared to last year's first quarter net loss of $98.4 million, or 11 cents per share.